Elevated circulatory DPP4 levels and activity have been found in a wide spectrum of metabolic syndromes, including diabetes, obesity, cardiovascular diseases, and nonalcoholic fatty liver diseases. Here, DPP4 is linked to obesity due to melanocortin 4 receptor deficiency.